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Abstract
Background: Dysregulation of host immune responses plays a critical role in the pathogenesis of severe 2009 pandemic
H1N1 infection. Whether H1N1 virus could escape innate immune defense in vivo remains to be investigated. The aim of
this study was to evaluate the pattern of innate immune response during human 2009 H1N1 infection. We performed the
enumeration of circulating myeloid dendritic cells (mDC) and plasmacytoid DC (pDC) in blood from patients with H1N1
pneumonia shortly after the onset of symptoms and during follow-up at different intervals of time. The analysis of CD4 and
CD8 count, CD38 T-cell activation marker and serum cytokine/chemokine plasma levels was also done.
Methodology/Principal Findings: Blood samples were collected from 13 hospitalized patients with confirmed H1N1-related
pneumonia at time of admission and at weeks 1, 4, and 16 of follow-up. 13 healthy donors were enrolled as controls. In the
acute phase of the disease, H1N1-infected patients exhibited a significant depletion in both circulating pDC and mDC in
conjunction with a decrease of CD4 and CD8 T cell count. In addition, we found plasmatic hyperproduction of IP-10 and
RANTES, whereas increase in T-cell immune activation was found at all time points. When we assessed the changes in DC
count over time, we observed a progressive normalization of mDC number. On the contrary, H1N1-infected patients did not
achieve a complete recovery of pDC count as values remained lower than healthy controls even after 16 weeks of follow-up.
Conclusions: H1N1 disease is associated with a profound depletion of DC subsets. The persistence of pDC deficit for several
weeks after disease recovery could be due to H1N1 virus itself or to a preexisting impairment of innate immunity.
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Introduction
Since the onset of the 2009 influenza A (H1N1) pandemic, the
virus has caused significant morbidity and mortality [1]. Although
older patients and those with comorbidities are more likely to
experience worse clinical outcomes, many severe cases occur in
healthy young adults; approximately one quarter to one half of
patients with 2009 H1N1 virus infection who were hospitalized or
died had no reported coexisting medical conditions [2–4]. The
pattern of host immune response to 2009 H1N1 virus infection in
humans is not fully elucidated [5]. Recent studies have showed
that increased cytokine and chemokine plasma levels are markers
of critical illness, suggesting that immunopathology may contrib-
ute to the disease severity [6,7]. An important role of Th1 and
Th17 response in H1N1 infection as early distinctive hallmarks of
severe respiratory impairment has also been suggested [8]. In
addition, T cells from pandemic H1N1-infected patients present-
ing with severe or fatal clinical course resulted in impaired effector
cell differentiation and profound functional anergy [9]. To date,
the role of host innate immune responses in H1N1-infected
patients has been little explored. In a recent study assessing the
effect of 2009 H1N1 virus on the human immune system, it has
been shown that infection by the H1N1 virus is accompanied by a
characteristic impairment of the innate immune responses
characterized by a selective defect in cytokine responses to
Streptococcus pneumoniae [10]. Osterlund et al. also showed that the
2009 H1N1 virus was able to escape the host innate immune
response by interfering with antiviral and proinflammatory
cytokine gene expression in human macrophages and dendritic
cells (DC) [11].
DC are key effector cells in innate immunity for the first line
defense against viral infection [12–14]. During influenza virus
infection, DC secrete antiviral cytokines, activate virus-destroying
natural killer cells and stimulate T cells with production of
neutralizing antibodies, which, together, are responsible for virus
clearance. Two types of DC that can be identified by phenotypic
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blood: myeloid DC (mDC) and plasmacytoid DC (pDC). mDC
express CD11c, require granulocyte-macrophage colony-stimulat-
ing factor (GM-CSF) for growth and survival and perform antigen
uptake, T cell activation and secretion of interleukin (IL)-12 and
IL-18. pDC express CD123, are dependent on IL-3 for survival
and rapidly produce large amounts of interferon (IFN)-a type I in
response to viral infections, including influenza virus. IFN-a
production by pDC plays a pivotal role in immune response
against flu [15].
In order to investigate the pattern of innate immune response
during human 2009 H1N1 virus infection, we performed a
longitudinal assessment of DC in blood from patients with H1N1
pneumonia shortly after the onset of symptoms and during follow-
up at different intervals of time. A direct enumeration of
circulating mDC and pDC was performed in conjunction with
analysis of CD4 and CD8 count, T-cell activation markers and
serum cytokine/chemokine plasma levels. Our data showed that
2009 pandemic H1N1 virus infection is associated with a severe
impairment of the innate immune responses characterized by a
profound depletion of pDC subset, which persists for several weeks
after recovery of the disease.
Materials and methods
Ethics Statement
The study was approved by the institutional review board
(Department of Infectious and Tropical Diseases, Sapienza
University of Rome). All study participants gave informed written
consent.
Study population
The study population included a total of 13 patients with
confirmed 2009 H1N1 influenza A admitted at the Infectious
Disease Units of Sapienza University of Rome (Policlinico
Umberto I Hospital) and Latina (SM Goretti Hospital).
Nasopharyngeal-swab specimens were collected at admission
and real-time reverse-transcriptase polymerase chain reaction
(RT-PCR) was performed in each institution or centralized in a
reference laboratory. All enrolled patients had acute respiratory
illness with opacities found on the chest X-ray (revealing
pneumonia) and had laboratory-confirmed pandemic 2009
H1N1 virus infection by real-time RT-PCR. No microbiologic
evidence of other viral or bacterial respiratory infections was
detected. 13 sex and aged-matched healthy controls with no flu
symptoms in the last 4 weeks were enrolled as controls. For each
enrolled patients venous blood samples were collected into
heparinized glass tubes and ethylenediaminetetraacetic acid
(EDTA)-containing tubes at time of admission (week 0) and at
week 1, 4, and 16 of follow-up.
Reagents
TruCOUNT
TM tubes, FACS Lysing Solution, and monoclo-
nal antibodies (mAbs) for DC labeling anti-CD45- peridinin
chlorophyll (PerCP), anti-HLA-DR- allophycocyanin (APC),
Lineage-fluorescein isothiocyanate (FITC) cocktail composed of
anti-CD3 (SK7), anti-CD14 (MP9), anti-CD16 (3G8), anti-CD19
(SJ25C1), anti-CD20 (L27), anti-CD56 (NCAM 16-2), and anti-
CD11c- phycoerythrin (PE) or anti-CD123-PE), for isotype
control (mouse anti-IgG1a-PE and mouse anti-IgG2a-PE) and
for CD4 count CD4-FITC and CD8-PerCP were used. All mAbs,
TruCOUNT
TM tubes and FACS Lysing Solution were pur-
chased from Becton Dickinson (BD Biosciences Pharmingen,
Italy).
Enumeration of plasmacytoid DC and myeloid DC
DC enumeration was done using TruCOUNT tubes and lyse
no-wash whole blood analysis, as previously described [16,17].
Samples were analyzed within 1–3 h of staining using a
FACScalibur flow cytometer and CellQuest version 1.0 (Becton
Dickinson, Mountain View CA). All data were collected using
identical instrument settings. DC were identified as lineage-
negative cells and HLA-DR-APC positive cells. Then to define
mDC and pDC, CD11c-PE and CD123-PE were respectively
used in two different tubes. To calculate the blood absolute pDC
or mDC number (cells/ml) we used the known formula as
previously described [16,17].
Monocyte and CD4 and CD8 T-cell count
A standard whole blood lyse/no wash TruCOUNT assay was
used to calculate also the number of T lymphocytes CD4+ and
CD8+ using anti-CD4-PE and anti-CD8-FITC and anti-CD45-
PerCP. Monocytes were identified with anti-CD14-PE and anti-
CD45-PerCP.
Measurement of CD4 and CD8 T-cell activation
CD4 and CD8 cell activation was assessed on whole blood cells
by using a lyse/no wash procedure. The percentage of CD4 and
CD8 cells that expressed CD38 and human leukocyte antigen
(HLA)-DR, activation markers, was determined using PE-
conjugated anti-CD38, FITC-conjugated anti-HLA-DR, PerCP-
coniugated anti-CD45- and APC-conjugated anti-CD4, or APC-
conjugated anti-CD8 monoclonal antibodies and analyzed by flow
cytometry.
Cytokine and chemokine determination
Cytokines and chemokines were measured in plasma
prepared from blood that had been collected into EDTA-
containing tubes and stored at 280uC. Instant enzyme-linked
immunosorbent assays (ELISA) (Bender MedSystems, Vienna,
Austria) were used for the quantitative detection of IFN-a,
tumour necrosis factor (TNF)- a, IL-6, CCL3/macrophage
inflammatory protein-1 (MIP-1a), CCL4/macrophage inflam-
matory protein-1 (MIP-1b), CCL5/regulated upon activation,
normal T-cell expressed, and secreted (RANTES). Quantikine
ELISA (R&D system, Abingdon, UK) was used for testing IFN-
c-inducible protein 10 (IP-10), IFN-c, IL-15 and IL-17. The
assays were performed in accordance with the instructions of
the manufacturers. The detection limit of each cytokine assay
was: 3.16 pg/ml for IFN-a,1 . 6 5p g / m lf o rT N F - a,8p g / m l
for IFN-c, 2 pg/ml for IL-15, 15 pg/ml for IL-17, 1.67 pg/ml
for IP-10, 0.92 pg/ml for IL-6, 6 pg/ml for CCL3/MIP-1a,
3 pg/ml for CCL4/MIP-1b, 4.2 pg/ml for CCL5/RANTES.
For statistical analysis, samples below the detection limit were
arbitrarily assigned the value for the detection limit in the
assays.
Statistical analysis
SPSS version 13.0 for windows (SPSS Inc., Apache Software
Foundation, Chicago, Illinois) was used. Results are presented as
median and range. Data at multiple time points were compared
using the Friedman two-way analysis of variance by ranks followed
by the Dunnett’s multiple comparison post-test. The differences of
values between the healthy controls and the patients were
analyzed using the non-parametric Mann-Whitney U-test. The
significance of correlation analysis was estimated using the
Spearman’s rank correlation test. P-value ,0.05 was regarded as
significant.
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Demographics and clinical characteristics of study
population
Among the 13 enrolled patients, six were males and seven
females (median age, 44 years; range 31–56) (Table 1). None of the
patients had received the vaccine against pandemic 2009 H1N1
virus. Two patients were pregnant, 7 had obesity with a body mass
index (BMI) .30, 3 had chronic obstructive pulmonary disease
(COPD); 1 was diabetic; 5 subjects didn’t have any known risk
factor. The median days from onset of symptoms to hospitalization
was 3 (range 1–4). All patients received oseltamivir by the day of
hospitalization. Lung involvement with more than one opacity in
initial x-ray chest was present in 11 of 13 patients. Eight patients
showed a PaO2/FiO2 ratio below 250 assessed at 0.31% of pO2.
Three patients required non-invasive ventilation by continuous
positive airway pressure (CPAP). No patients required mechanical
ventilation.
Circulating plasmacytoid DC and myeloid DC
Circulating pDC and mDC were quantified in 13 patients with
H1N1 infection at the time of hospitalization and at different
intervals of time during follow-up using the single-platform
TruCOUNT assay (Figure 1). A significant reduction in both
circulating pDC and mDC was found in H1N1-infected patients at
baseline when compared with 13 age- and sex-marched healthy
donors (p,0.001 for both). Indeed, in patients affected by 2009
pandemic H1N1 influenza the median (range) DC counts
(cells/ml) were as follows: 1420 (range 7655–88) for pDC versus
10967 (3875–52111) of controls and and 3652 (7897–387) for
mDC versus 14064 (1662–45917) of controls. During follow-up,
we observed a rapid and significant augmentation in mDC
numbers; indeed, the median (range) mDC count increased to
8034 (720–24603) at week 1, 10700 (742–25781) at weeks 4, and
8986 (750–39057) at week 16 (p, 0.05 for weeks 1, 4, and 16
versus baseline). At the end of follow-up the values of mDC were
within normal ranges. With regard to pDC, there was a slight
increase of the cells over time; the median of pDC increased to
2882 (0–9856) at week 1, 4287 (26–11985) at weeks 4, and 3013
(32–9805) at week 16 (p ,0.05 for weeks 4, and 16 versus
baseline). Interestingly, H1N1-infected patients did not achieve a
complete recovery of pDC count as values remained significantly
lower than healthy controls at all time points. Although obesity
was considered a major risk factor for the severity of lung disease,
no correlation between DC count and BMI was found. A
representative cytometry analysis of one H1N1-infected patient
during follow-up is showed in figure 2. During the current seasonal
flu we have examined 4 outpatients with mild H1N1 disease (no
pulmonary involvement) and no deficit in the peripheral numbers
of either mDC or pDC was found (data not shown).
Circulating monocytes, CD4+ and CD8+ T-cell count
Changes in monocytes, CD4+ and CD8+ T-cells in study
population are shown in Table 2. Values of monocytes were within
normal ranges in H1N1-infected patients and no significant
changes were found over time in comparison to controls. On the
other hand, baseline CD8 and CD4 T lymphocyte count was
significantly lower compared with healthy controls (p,0.05 for
both). At follow-up analysis, we observed a prompt and significant
increase in both CD4 and CD8 count with normalization of
values.
T-cell activation markers
In order to measure the degree of T-cell activation during 2009
pandemic H1N1 virus infection, we assessed the percentage of
CD4+ and CD8+ cells that expressed the activation markers
Table 1. Demographic and clinical characteristics of the 13 patients affected by pandemic H1N1 influenza.





001 48 F Obesity/Type II diabetes 49 72 175 CPAP 4
002 51 M Obesity 35 84 207 CPAP 3
003 31 M Obesity/COPD 58 82 309 O2 therapy by
ventimask
4
004 53 M Obesity/COPD 34 79 214 CPAP 3
005 31 F None 20 95 309 O2 therapy by
ventimask
2
006 30 F Pregnancy 25 98 428 None 1
007 38 F None 24 94 350 O2 therapy by
ventimask
2
008 52 M Obesity/Asthma 38 91 313 O2 therapy by
ventimask
4
009 38 M None 27 90 250 O2 therapy by
ventimask
1
010 44 M Obesity 34 85% 302 O2 therapy by
ventimask
2
011 31 F None 27 89 299 O2 therapy by
ventimask
2
012 56 M COPD/Obesity 32 77 245 CPAP 3
013 45 F None 23 82 289 O2 therapy by
ventimask
2
BMI: body mass index; Sat: saturation; CPAP: continuous positive airway pressure; COPD: chronic obstructive pulmonary disease.
doi:10.1371/journal.pone.0019872.t001
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patients exhibited at baseline a significantly higher percentage of
double positive DR+/CD38+ in both CD4 and CD8 in
comparison with controls (median [range] 1,65 [0.25–4.24] for
DR+/CD38+/CD4+ and 3,1 [0.42–8.14] for DR+/CD38+/
CD8+ versus 0.3% [0.013–2.12] and 0.15% [0.00–3.2] of
controls, respectively) (p,0.05). T-cell immune activation markers
persisted elevated during the overall period with a significant
difference between cases and controls at week 16 of follow-up
(p,0.01).
Plasma concentrations of cytokines and chemokines
In another set of experiments, we assessed circulating levels of
cytokines (TNF-a, IFN-a, IFN-c, IP-10, IL-6, IL-15, IL-17) and
chemokines CCL3/MIP-1a, CCL4/MIP-1b, CCL5/RANTES
(Figure 4). No detectable plasma concentrations of TNF-a, IL-6,
IL-15 and IFN-a were found. CCL3/MIP-1a, CCL4/MIP-1b,
IFN-c and IL-17 were detectable in small amounts in a low
number of patients. On the other hand, the highest concentrations
were found for IP-10 (median 1079 pg/ml, range 92-1137) and
RANTES (median 647 pg/ml, range 0–875). These levels were
significantly higher than those obtained in the control group
(p,0.01 for both IP-10 and RANTES) (Figure 4). Longitudinal
analysis showed a rapid decrease of altered cytokine IP-10 and
chemokine RANTES just after 1 week of follow-up (data not
shown).
Discussion
The novel 2009 H1N1 virus infection emerged as the first
influenza pandemic of the 21
st century and it has been associated
with acute severe pneumonia that resulted in high morbidity and
mortality [18,19]. Although smoking, pregnancy and obesity have
been highlighted as risk factors for severe pneumonia, high
percentage of fatal cases had no evident underlying medical
condition and occurred in previously healthy individuals [2].
Whether the severity of human 2009 H1N1 disease could be due
to the direct pathogenic effect of virus itself or to a dysregulation of
the immune system remains to be investigated. Recent lines of
evidence suggest that a virus-driven dysregulation of host response
leading to an exaggerated production of inflammatory cytokines
and chemokines plays a contributing role in the pathogenesis and
severity of human H1N1 disease [8].
In the present study, we have investigated the role of innate
immune response in patients with H1N1 2009 related-pneumonia
by assessing in the peripheral blood the circulating number of DC.
We demonstrated that during the acute phase H1N1-infected
patients exhibited a specific and significant decrease in the
absolute number of circulating DC when compared to healthy
donors. The reduction affects the two main subsets of DC
circulating in the peripheral blood, i.e. mDC and pDC. The
importance of DC in the initiation and control of innate and
adaptive immune responses against influenza infection is well
documented [14–16]. Once activated, DC promote the stimula-
tion of CD4 and CD8 T cells by inducing a specific response with
the production of neutralizing antibodies and secretion of direct
antiviral cytokines, such as IFN-a, which, together, contribute to
elimination of viral infection. The different subpopulations of DC
are involved in the regulatory immune mechanisms during
influenza. mDC are characterized by a high susceptibility to
influenza virus and, when infected, produce cytokines, as IL-12,
IL-23 and TNF-a, and may induce the activation of specific
cytotoxic CD8+ T lymphocytes via IL-15. pDC are the main IFN-
a producing cells and are essential for viral clearance [20]. In our
patients the levels of circulating IFN-a were persistently undetect-
able. Whether the impairment in IFN-a secretion could be related
to a clear defect in the function of pDC or to a simple numerical
reduction of these fundamental antigen presenting cells (APC) is
unclear. Various possible mechanisms could be involved in
peripheral DC deficiency during H1N1 disease. One hypothesis
is that these cells are more susceptible to apoptosis during viral
infection and may undergo peripheral destruction. However, it is
conceivable that the low number of peripheral DC fractions could
be due to their enhanced recirculation from blood to affected
tissues, such as inflamed lung or lymph nodes. Recent experiments
in mouse showed that a subset of DC, described as TNF-a
inducible nitric oxide synthase (iNOS)-producing DC (tipDC)
[21], accumulate in significantly greater numbers in the lung
during the course of lethal influenza [22]. The DC recirculation
Figure 1. Circulating myeloid dendritic cells (mDC) and
plasmacytoid DC (pDC) in pandemic H1N1-infected patients
and controls. Box plots show the 10th, 25th, 50th(median), 75th and
90th percentile and outlying values. Gray box plots represent the
number of circulating mDCs (upper panel) and pDCs (lower panel) in 13
H1N1-infected patients at baseline (week 0) and during follow-up (week
1, 4 and 16). White box plots indicate 13 sex and aged-matched healthy
controls. Asterisks indicate significant decrease of mDC and pDC
(p,0,05 versus controls).
doi:10.1371/journal.pone.0019872.g001
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has been associated to an augmentation in lymph nodes and spleen
[23,24].
In our patients in the acute phase of disease we also found a
significant decrease of CD4 and CD8 T cells, while monocytes
were within normal ranges. In addition, at the time of admission,
we observed an increase in CD38 T-cell immune activation and
plasmatic hyperproduction of IP-10 and RANTES. These findings
are in agreement with a recent study which demonstrated that the
early immune response in H1N1-infected patients is characterized
by a rapid generalized lymphopenia associated with preferential
loss of Th17 population and marked T cell activation [25]. The
deficit of T-cell count was promptly restored just after 1 week of
follow-up in conjunction with a rapid decrease of cytokine IP-10
and chemokine RANTES. On the other hand, the expression of
T-cell CD38 immune activation marker persisted elevated during
the overall period of the study. When we assessed the longitudinal
changes in DC count, we observed a progressive augmentation in
Figure 2. Cytometry analysis of mDC and pDC in one representative H1N1-infected patient at baseline and during follow-up. The
gating strategy to define DC population (lineage negative, HLA-DR positive) is illustrated in the upper dot plots. In the lower contour plots mDC
(CD11c+) and pDC (CD123+) definition is showed at diagnosis (week 0) and during follow-up (week 1, 4 and 16).
doi:10.1371/journal.pone.0019872.g002
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follow-up. On the contrary, H1N1-infected patients did not
achieve a complete recovery of pDC count as values remained
significantly lower than healthy controls during the overall period
of the follow-up. During the 4 months of follow-up the persistent
Table 2. Blood monocytes, CD4+ and CD8+ T-cell count in 13 patients with pandemic H1N1 influenza and 13 healthy controls.
Patients Controls
Week 0 Week 1 Week 4 Week 16
Monocytes cells/ml 542 (187–1202) 612 (212–1248) 597 (235–1210) 420 (154–1002) 560 (421–1006)
CD4 + T cells/mmc *360 (112–1057) 573 (215–1371) 835 (248–1458) 875 (321–1622) 888 (758 1521)
CD8 + T cells/mmc *268 (93–544) 388 (151–835) 525 (168–903) 517 (187–900) 558 (325–908)
Results are expressed in median (range).
Asterisks indicate significant decrease (p,0.05 versus controls).
doi:10.1371/journal.pone.0019872.t002
Figure 3. CD4+ and CD8+ T cell activation markers in pandemic






th percentile and outlying values. Gray box
plots represent the percentage of CD4+ T cells (upper panel) and CD8+
T cells (lower panel) that express activation markers CD38/HLA-DR in 13
H1N1-infected patients at baseline (week 0) and during follow-up (week
1, 4, and 16). White box plots indicate 13 sex and aged-matched healthy
controls. Asterisks indicate a significant increase in percentage of
double positive DR+/CD38+ in both CD4+ and CD8+ T cells (p,0,05
versus controls).
doi:10.1371/journal.pone.0019872.g003
Figure 4. Plasma levels of chemokines and cytokines in
pandemic H1N1-infected patients and controls. Dot plot
represent circulating levels of chemokines CCL3/MIP-1a, CCL4/MIP-1b,
CCL5/RANTES (upper panel) and cytokines TNF-a, IFN-a, IFN-c, IP-10,
IL-6, IL-15, IL-17 (lower panel) in 13 H1N1-infected patients at the time of
hospitalization. Black circles indicate 13 sex and aged-matched healthy
controls. Only the levels of IP-10 and RANTES were significantly higher in
patients in comparison with the control group (p,0.01 for both).
doi:10.1371/journal.pone.0019872.g004
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T-cell immune activation. In summary, it was found that DCs and
T cells are diminished in the blood, and T cells display an
activated phenotype for the duration of the study. One
interpretation of the data is that both populations of cells are
recruited to other tissues, such as lymph nodes, where the cells
interact and the T cells are activated.
Variouspossible mechanisms could be involved in the persistence
of pDC depletion for several weeks even after H1N1 disease
recovery. One hypothesis is that H1N1 virus itself might continueto
induce a direct effect on pDC with a prolonged recirculation in the
lung and lymph nodes which could lead to immune activation
status. Another possible explanation could be a preexisting
impairment of innate immunity. Indeed, we cannot exclude that
thedeficitofpDCwaspresentinourpatientsbeforeH1N1infection
and it might be responsible for viral lung spread by decreasing IFN-
a production and increasing T cell activation. Recently, a close
association between impaired host immune competence and a
severe or fatal clinical course of H1N1 infection has been reported
(9). Agrati et al. showed that T cells from patients with severe H1N1
infectionexhibitedimpaired effector cell differentiation and failed to
respond to mitogenic stimulation. The anergy of T-cell response is
probably related to apoptotic mechanisms and could expose the
host to viral damage and to secondary infections in the lung. In a
recent study, H1N1-infected patients with severe respiratory disease
are characterized by the impaired activation of genes participating
in the development of the antiviral adaptive response and by
persistence of the virus in the lung. In particular, poor expression of
a number of genes involved in B-cell development, T-helper cell
differentiation, CD28, granzyme B signaling, apoptosis and protein
ubiquitination has been reported. In addition, the impaired
expression of genes participating in dendritic cell maturation, such
asCCR7,CD1C,IL-18,suggeststhepresenceofa defectiveantigen
presentation [26]. In the present investigation, we did not perform
the analysis of gene expression profiles; however, it is possible that
the persistent impairment of pDC seen in our patients could be due
to altered expression levels of the genes participating in the antigen
presentation pathway induced by the virus. In a large comprehen-
sive immunologic analysis of Indian H1N1-infected patients,
Arankalle et al. provided evidence of a profound impairment of
host immune response; they showed that the majority of the
immune-function genes were down-regulated in the periphery and
up-regulated in the lung cells [27]. This profile of gene expression
supports our hypothesis on the infiltration of monocytes/DCs/
macrophages to the target pulmonary tissue for mounting immune
response and/or tissue repair.
Finally, we cannot exclude that underlying conditions such as
obesity, type II diabetes, asthma, or COPD could affect circulating
DC count or levels or cytokines/chemokines. In particular, obesity
represents major risk factor for the severity of lung disease but was
present only in 7 patients. Nevertheless, we did not find any
significant correlation between DC count, chemokine/cytokine
levels and BMI.
Our study has obvious limitations due the lack of analysis of
viral load kinetics and their potential correlation with immuno-
logic parameters. In previous studies, a clear correlation between
viral load and clinical and immunologic outcome has not been
established thus suggesting that factors other than viral replication
can be responsible for more severe clinical disease [9]. The present
work included only subjects with confirmed influenza pneumonia;
in this respect, we were not able to detect immunologic differences
between different clinical patterns of H1N1 infection, ranging
from asymptomatic infection to more severe form of the disease.
During the current seasonal flu we are following outpatients with
mild H1N1 disease (no pulmonary involvement) and until now we
have not found a defect in blood number of both mDC and pDC.
Unlike other studies, ours represents the first attempt to perform a
longitudinal analysis of the pattern of innate immune response
following several weeks after H1N1 infection.
In conclusion, the present study suggests that 2009 human
H1N1 disease was associated with a profound depletion of DC
subsets. The underlying mechanisms involved in the persistence of
pDC deficit even after several weeks after disease recovery are not
still elucidated. Nevertheless, these findings underline the impor-
tance for monitoring host innate response to H1N1 infection in
order to identify not only patients who have an enhanced risk of
developing severe complications, but also to detect preexisting
immune impairment in apparently immunocompetent cases.
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